GrantExec

Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)

This funding opportunity supports innovative research into how inflammasome activation affects individuals with HIV and substance use disorders, aiming to uncover mechanisms and potential therapeutic targets to improve health outcomes.

$275,000
Closed
Nationwide
Key Dates

Application Opens

October 17, 2023

Application Closes

October 28, 2024

Contact Information

Grantor

U.S. Department of Health & Human Services (National Institutes of Health)

Subscribe to view contact details

Newsletter Required
Categories
Education
Health